You have 9 free searches left this month | for more free features.

Histiocytic Sarcoma (HS)

Showing 1 - 25 of 1,734

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston

Active, not recruiting
  • Langerhans Cell Histiocytosis (LCH)
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 26, 2022

Histiocytic Disorder Follow-up Study

Recruiting
  • Histiocytosis
  • +5 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 13, 2023

    Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma, Erdheim-Chester Disease Trial in Memphis, Houston (Cobimetinib)

    Recruiting
    • Langerhan's Cell Histiocytosis
    • +6 more
    • Phoenix, Arizona
    • +6 more
    Jan 12, 2023

    Osteosarcoma, Sarcoma Trial (HS-20093)

    Not yet recruiting
    • Osteosarcoma
    • Sarcoma
    • (no location specified)
    Apr 26, 2023

    Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +108 more
    Oct 19, 2022

    Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

    Unknown status
    • Sarcoma
    • +16 more
    • Sequential chemotherapy - 3 courses of AI
    • Hypofractionated radiotherapy
    • Warsaw, Mazovian, Poland
      Maria Sklodowska-Curie Institute - Oncology Center
    Jan 19, 2021

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +44 more
    • Biopsy
    • +23 more
    • Birmingham, Alabama
    • +166 more
    Feb 2, 2023

    Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +31 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +118 more
    Jan 27, 2023

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +37 more
    • Birmingham, Alabama
    • +171 more
    Aug 24, 2022

    Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

    Recruiting
    • Malignant Solid Neoplasm
    • +26 more
    • Birmingham, Alabama
    • +121 more
    Aug 24, 2022

    Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +30 more
    • Larotrectinib Sulfate
    • Birmingham, Alabama
    • +123 more
    Aug 23, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +32 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +124 more
    Aug 24, 2022

    Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

    Recruiting
    • Malignant Solid Neoplasm
    • +40 more
    • Biospecimen Collection
    • +6 more
    • Birmingham, Alabama
    • +172 more
    Jan 27, 2023

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +113 more
    Jun 28, 2022

    Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

    Recruiting
    • Sarcoma,Soft Tissue
    • Tenerife, Canarias, Spain
    • +10 more
    Oct 27, 2023

    Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG), Rosai-Dorfman Disease (RDD) Trial (Mirdametinib)

    Not yet recruiting
    • Langerhans Cell Histiocytosis (LCH)
    • +3 more
    • (no location specified)
    Nov 22, 2023

    Sarcoma, Soft Tissue Trial in Orange (Pembrolizumab, Stereotactic body radiation therapy)

    Recruiting
    • Sarcoma, Soft Tissue
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Aug 9, 2022

    Sarcoma,Soft Tissue Trial in Barcelona, Madrid, Zaragoza (Selinexor)

    Recruiting
    • Sarcoma,Soft Tissue
    • Barcelona, Spain
    • +5 more
    Nov 16, 2021

    s to Diagnose Acute Myocardial Infarction in Elevated Hs-cTnT

    Completed
    • Acute Myocardial Infarction
    • No Intervention
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Sep 26, 2023

    Switching From Cardiac Troponin I to T

    Recruiting
    • Acute Coronary Syndrome
    • +5 more
    • Clinical implementation of hs-cTnT
    • Edinburgh, United Kingdom
      Centre for Cardiovascular Science
    Feb 17, 2023

    Hidradenitis Suppurativa, Acne Inversa Trial (Nd:YAG laser hair removal, Clindamycin 1 % Topical Lotion)

    Not yet recruiting
    • Hidradenitis Suppurativa, Acne Inversa
    • Nd:YAG laser hair removal
    • Clindamycin 1 % Topical Lotion
    • (no location specified)
    Feb 28, 2023

    Nutritional Status on Oncologic and Operative Outcome in

    Recruiting
    • Retroperitoneal Sarcoma
    • +5 more
    • Measurement of body composition with computed tomography (CT)
    • +5 more
    • Ljubljana, Slovenia
      Institute of Oncology Ljubljana
    Dec 2, 2022

    Renal Cell Carcinoma Trial (HS-10516)

    Not yet recruiting
    • Renal Cell Carcinoma
    • (no location specified)
    Sep 24, 2023